Shots: Ironwood to receive three non-contingent payment of $35M b/w 2021 & 2024, ~$90M as a milestone with royalties on sales of Linzess in China mainland, China Hong Kong and […]readmore
Tags : Commercializing
Shots: Merck exercises its option to extend its Feb,2015 agreement with NGM for development and commercialization of novel biologics therapies. NGM to receive $20M as an extension fee for R&D […]readmore
Shots: ITROM to get exclusive commercialization rights for Mithra’s Myring in MENA territories (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman, Lebanon, and Jordan) with a total deal value of $6.79M. […]readmore